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Theoretical insight into the antioxidant properties
of melatonin and derivatives†
Jeﬀrey R. Johns*a and James A. Plattsb
Density functional theory calculations on melatonin, metabolites and synthetic derivatives thereof, and a
range of other biological antioxidant molecules are presented, with a view to understanding the anti-
oxidant ability of these molecules. After testing of the necessary calculations, we show that melatonin lies
close to vitamin E on a donor–acceptor map, indicating that it should be an excellent electron donor but
a poor acceptor. The neutral radical metabolite of melatonin is predicted to be an even better donor,
whereas other metabolites and synthetic derivatives should retain antioxidant ability but are less powerful
than the parent. QSAR models of antioxidant activity, measured in two diﬀerent assays, are presented. We
show that octanol–water partition coeﬃcient is an excellent predictor of activity in lipophilic media, while
properties related to electron donor/acceptor power give good ﬁts against activity in aqueous media.
Introduction
Melatonin (N-acetyl-5-methoxytryptamine) is a naturally occur-
ring molecule, biosynthesized from the precursor amino acid
tryptophan, primarily by the pineal gland of vertebrates.1 Mela-
tonin has been extensively reported as a potent antioxidant,
both in vitro2 and in vivo.3–5 Much of its eﬀectiveness in vivo
may be attributed to the cascade of melatonin antioxidant
metabolites produced.6,7 Unlike most small-molecule biologi-
cal antioxidants such as vitamin C (ascorbic acid), α-toco-
pherol (vitamin E), lipoic acid etc., melatonin does not redox-
cycle. It undergoes molecular rearrangement, eﬀectively
removing the free electron from the system – a so-called
suicidal antioxidant (Fig. 1). Each of these products of
rearrangement is also a potent antioxidant in its own right.2,8,9
Furthermore, most of these processes involve more than one
reactive oxygen species (ROS) per step, so that one melatonin
molecule could scavenge up to 10 radical species before the
final metabolite is eliminated form the body.10 Additionally,
the relative position of melatonin and its metabolites in the
antioxidant “pecking order” (electrochemical potential) may
contribute greatly to its utility in biological systems.11
Melatonin is finding great utility in preventing diseases
related to oxidative damage including cancer12 and neuro-
degenerative diseases13,14 as well as its well known role in treat-
ment for reducing insomnia, jet lag, migraine, headache,
etc.13,15,16 It is being widely investigated for a large number of
other diseases in a large number of clinical trials.17 In
addition, consumption of tropical fruits containing melatonin
has been shown to reduce antioxidant levels in humans.5,18
The antioxidant radical scavenging properties of melatonin
and its metabolites cyclic-3-hydroxymelatonin (cyclic-3OHM),10
N(1)-acetyl-N(2)-formyl-5-methoxykynuramine) (AFMK), N(1)-
acetyl-5-methoxykynuramine (AMK)7 and 6-hydroxymelatonin
(6-OHmel)19 occurs mainly via the one electron transfer
process.8,20,21 The first ionization potential (IP) and the elec-
tron aﬃnity (EA) are properties of a system that allow measure-
ment of its propensity to donate or accept one electron. The
best antioxidants present low IP values, because the lower the
IP, the easier the electron abstraction, and vice versa for EA
and electron acceptance (antireductant).
Gazquez et al.21 have presented an elegant model to explain
relative scavenging activity and antioxidant power of com-
pounds using these two properties. Quantum chemical density
functional theory (DFT) calculations can be used to obtain
accurate ionization potentials, electron aﬃnities, electrodonat-
ing, and electroaccepting power indexes (with respect to
internal standards, such as fluorine and sodium atoms). These
values can then be used to construct a donator acceptor map
(DAM), indicating whether molecules are good electron donors
or acceptors. The DAM is a powerful representation of these
key properties, helping to reveal the antiradical capacity of any
substance and allowing qualitative comparison between sub-
stances, alongside quantitative measures obtained from experi-
ment or theory. Previous DAM studies have included linear
polyene-conjugated molecules,23 carotenoids,24 a large series
of carotenoids,25 carotenoids, melatonin and vitamins,26 and
psittacofulvins and anthocyanins.27†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4ob01396d
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Vitamin E or α-tocopherol has been described the “last line
of defense” in a multicomponent endogenous antioxidant
system.28 It appears that under conditions of stress, depletion
of cellular ascorbic acid occurs first, followed by glutathione,
then α-tocopherol, resulting in initiation of lipid peroxidation.
When glutathione is depleted, ascorbic acid plays a vital role
in maintaining cellular α-tocopherol levels and survival of the
cell.29 One might expect that melatonin should be depleted
after α-tocopherol, particularly in membranes,30 as it is higher
in the electrochemical series at 700 mV,8 compared to 500 mV
for α-tocopherol.11 Melatonin may therefore truly be the last
line of defense against oxidative damage.31 The role of melato-
nin in this multicomponent antioxidant is still unclear,
although there is evidence that melatonin cause upregulation
of superoxide dismutase, glutathione reductase and catalase.32,33
Several melatonin derivatives that were substituted on the
indole nitrogen (Fig. 2) have been previously reported for
in vitro antioxidant eﬀects and anti-inflammatory activities.34
Their synthesis and characterization is described in this ref. 34.
The aim of this study was to investigate the antioxidant
radical scavenging properties of melatonin and its metabolites
cyclic-3OHM, AFMK, AMK and 6-hydroxymelatonin, and
several N-indole substituted derivatives via the one electron
transfer process, using a donor–acceptor map. Other classical
antioxidants and vitamins are modeled for comparison. QSAR
relationships of some N-indole substituted derivatives between
in vitro antioxidant properties experimentally measured by
lipid peroxidation of rat brain homogenate using thio-
barbituric acid reacting substances (TBARS IC50)
35,36 and
Oxygen Radical Absorbance Capacity Assay (ORAC) data, and a
number of derived electronic properties e.g. HOMO/LUMO
energies, donor and acceptor power (Rd, Ra), hardness, electro-
negativity and log P were investigated. The ORAC assay is
based on the scavenging of peroxyl radicals generated by 2,2′-
azobis (2-methylpropionamidine) dihydrochloride (AAPH) in
aqueous media, which prevent the degradation of the fluor-
escein probe and, consequently, prevent the loss of fluo-
rescence of the probe.37,38 The antioxidant activity was
calculated from the integrated area under the fluorescence
curve (AUC) for each antioxidant.
Methods
B3LYP/DFT as implemented in Gaussian09-RevC.0139 software
was used for all IP and EA calculations with complete optimi-
zations, without symmetry constraints. Geometries were first
minimized in Molecular Operating Environment MOE.40 Calcu-
lations were performed on the ARCCA/Raven Supercomputer
at Cardiﬀ University. Both vertical IE and EA, where energies
for the cation and anion were computed at the optimized geo-
metry of the ground state (single point), and relaxed (adiabatic)
IE and EA for optimized cation and anion geometries were calcu-
lated. Harmonic frequency analysis was used to verify opti-
mized minima using Molden.41
To determine the accuracy of DFT for predicting IP/EA of indole-
amines, calculations in gas phase using diﬀerent basis sets
Fig. 1 Transformation melatonin by antioxidant activity.
Fig. 2 Melatonin and N-indole substituted derivatives (R1 = OCH3,
NO2, benzoyl or naphthoyl).
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were compared to previously reported photoelectron spectro-
scopy measurements. IP and bond-dissociation energies for
many antioxidant systems do not follow the same trends in gas
and solution phases, such that major diﬀerences with respect
to vacuum are found as when water computations are per-
formed.42 On the basis of the computed BDE and IP values, to
more realistically model antioxidant activity in vivo, calcu-
lations were therefore performed using the polarizable conti-
nuum model (PCM water) i.e. placing the solute in a cavity
within the solvent reaction field.
The validity of using B3LYP for calculating EA has been
raised, due to most DFT functionals (including B3LYP) being
incapable of binding the whole excess electron.43 This may not
be revealed when using standard basis sets, even with multiple
diﬀuse functions, since they artificially constrain the electron
density to remain near the nuclei. The error due to this con-
straint depends on the magnitude of the EA, which could
render trends in EA unreliable, especially for low EAs. Thus a
range-separated DFT method, CAM-B3LYP,44 was used to investi-
gate the problem of fractional EA. A positive energy for the
HOMO of an anion species is an easy diagnostic for the frac-
tional EA problem.43
The melatonin molecule contains three freely rotatable
bonds in its imidazole side chain. To investigate the eﬀect of
conformation, MOE40 was used to select a range of typical con-
formers via stochastic search of rotatable bonds, using the
MMFF94 forcefield. 10 000 conformers were generated then
sorted into clusters based on dihedral angles of the freely rota-
table bonds. Vertical IP and EA of the lowest energy confor-
mers from each cluster were then calculated, following
geometry optimization of the neutral molecule. No significant
changes in geometry on DFT optimization were noted, indicat-
ing that conformers remained in their local energy minima.
Donor–acceptor maps were calculated following the
method of Martinez et al.,26 using the same experimental
values of IE and EA for sodium of 5.140 and 0.540 eV and for
fluorine of 17.540 and 3.400 eV respectively, taken from the lit-
erature. This set reference points on the map of Ra = 1 for the
sodium atom, and Rd = 1 for the fluorine atom. Values calcu-
lated using Gaussian 09/RB3LYP/6-31+G* gas phase were 5.406
and 0.596 eV for sodium and 21.405 and 3.513 eV for fluorine
respectively.
As formulated by Gazquez et al.22 and applied in the study
of Martínez et al.,27 the propensity to donate charge, or electro-
donating power, may be defined as:
ω ¼ ð3I þ AÞ
2
16ðI  AÞ
(where I is ionization potential and A is electron aﬃnity),
whereas the propensity to accept charge, or electroaccepting
power, may be defined as:
ωþ ¼ ðI þ 3AÞ
2
16ðI  AÞ
For electroaccepting power, higher values imply a greater
capacity for accepting charge, whereas for electrodonating
power, lower values imply a greater capacity for donating
charge. It should be noted that ω− and ω+ refer to fractional
charges, however I and A refer to donating or accepting a
single, whole electron. Thus, a simple charge transfer model,
framed in terms of chemical potential and hardness is used to
describe electrodonating and electroaccepting powers. The
charge flow direction is measured by chemical potential, along
with the capacity to donate or accept charge. More emphasis is
assigned to the ionization potential than to the electron
aﬃnity in the context of the charge donation process. Likewise,
more significance is assigned to electron aﬃnity than to
ionization potential for electroaccepting power. Hardness pro-
vides a measure of the resistance to the electron transfer. So
that a range of substances can be compared for electrodonat-
ing and electroaccepting power, experimental values of I and A
for sodium and fluorine are used a reference points to provide
corresponding ω+ and ω− values. Sodium represents a good
electron donor and fluorine represents a good electron accep-
tor. For some substance L, the electron acceptance index can
be defined as:
Ra ¼ ωL
þ
ωFþ
When Ra = 1, then ωL
+ ≈ ωF+ and L is as eﬀective an elec-
tron acceptor as fluorine. When Ra > 1, then ωL
+ > ωF
+ and L is
a more eﬀective electron acceptor than fluorine. When Ra < 1,
then ωL
+ < ωF
+ and L is a less eﬀective electron acceptor than
fluorine. Similarly, the electron donation index can be defined as:
Rd ¼ ωL

ωNa
When Rd = 1, then L is as eﬀective an electron donor as
sodium, and when Rd > 1, L is a less eﬀective electron donor
than sodium, whereas when Rd < 1, L is a more eﬀective elec-
tron donor. If Ra and Rd are determined, then any substance L
can be characterized in terms of its electron donor–acceptor
capacity, and mapped on a donor acceptor map (DAM).
Octanol–water partition coeﬃcients (log P) were estimated
using ACD/Chemsketch log P plugin (Advanced Chemistry
Development, Inc., Toronto, Canada, 2012), MarvinView 5.11.3
(Chemaxon, Budapest, Hungary, 2012) and MolKa (Molecular
Discovery Ltd, Perugia, Italy, 2012) and compared to literature
values where available.
Data on the antioxidant capacity of melatonin derivatives
in vitro, using the widely adopted method of Callaway et al.35
for measurement of lipid peroxidation, the thiobarbituric
acid reacting substances (TBARS) and brain homogenate, was
used in this study. Inhibitory eﬀect on nitric oxide (NO) of
melatonin and these derivatives has been previously reported
by our group.34
Results and discussion
DFT predictions of gas phase IP and EA for diﬀerent basis
sets (Fig. 3) compared favorably with the previously reported
Paper Organic & Biomolecular Chemistry
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photoelectron spectroscopy measurements and IP/EA of other
workers (Table 1). Although there were some diﬀerences
between values obtained with varying basis sets, these were
not large. It is notable, though, that smaller basis sets like
6-31G and 6-31G* incorrectly predict positive EA, and that
diﬀuse functions are necessary for qualitatively correct values.
Significantly, diﬀerences between vertical and relaxed values
were small, at any particular basis set. To optimise compu-
tational time, the 6-31+G* basis set was chosen for all further
calculations as using a larger basis sets did not result in sig-
nificant improvement in IP or EA values.
Using the CAM-B3LYP functional did not give significantly
diﬀerent EA values for melatonin using any of the basis sets in
this study. Furthermore, no positive energies for HOMO’s of
any anion species were observed. The reactivity indices calcu-
lated for compounds in this study depend mainly on the IP
values, rather than EA, as they are mostly electron donors, thus
small EA errors will have negligible impact on the overall
findings.
Comparison of reported values for IP and EA reported in
the literature is made with those calculated using B3LYP
6-31+G* basis set and gas phase in Table 1.
Eﬀect of conformation
Eﬀects of conformation of melatonin on calculated IP and EA
in PCM (water) are shown in Table 2. Values of IP and EA
calculated in PCM are quite diﬀerent from those in gas phase
due to the eﬀects of solvent polarization. However, confor-
mation changes resulted in less that 1.3% diﬀerence in IP and
8.4% diﬀerence in EA values in the PCM model. This is not
unsurprising, as removal or addition of an electron to the
neutral molecule would be expected to aﬀect the extensively
delocalized rigid indole moiety only, such that the confor-
mation of the imidazole side chain would have little impact on
these processes. Therefore, subsequent DFT calculations
reported below use the global energy minimum conformation
found from the stochastic search.
Donor acceptor map
Electron acceptance (Ra) and electron donation (Rd) indexes
were calculated from IP and EA, using fluorine and sodium as
references22 as previously described in the methods section.
The donor acceptor for melatonin, its metabolites and some
classical antioxidants is show in Fig. 4.
The donor/acceptor maps shows melatonin to be a very good
electron donor, along with its metabolites 6-hydroxymelatonin
and cyclic-3-hydroxymelatonin and the melatoninyl neutral
radical, and several classical antioxidants such as vitamin E
(α-tocopherol), epigallocatechin gallate (ECGC), resveratrol,
xanthurenic acid and quercetin (a typical flavenoid). Other
melatonin metabolites (AFMK, AMK) and melatonin derivatives
showed weaker electron donor strength, similar to other classi-
cal antioxidants such as vitamin A, vitamin C, beta-carotene and
α-lipoic acid. The 4-nitro derivative of melatonin is not shown
on the DAM and appears oﬀ the top right quadrant at Ra = 4.35
and Rd = 5.62, being a much poorer electron donor and better
electron acceptor than melatonin, due to its strongly withdraw-
ing nitro group. Interestingly, the melatoninyl neutral radical
that results from a 1-electron 1-proton donation from melatonin
is an even more powerful electron donor than melatonin itself.
These results are supported by a large number of
experimental observations where melatonin acts as a direct
scavenger of free radicals with the ability to detoxify both
reactive oxygen and reactive nitrogen species, and indirectly by
Fig. 3 Gas phase ionization potentials and electron aﬃnities using
diﬀerent basis sets.
Table 1 Reported photoelectron spectroscopy measurements (PES)
and DFT calculated IP/EA values for melatonin
7.76 IP PES45
7.03 IP PES46
7.7 IP Vertical26 Estimated from PES
6.83 IP Vertical26 Gaussian03 B3LYP/D95 V gas phase
−1.00 EA Vertical26 Gaussian03 B3LYP/D95 V gas phase
7.07 IP Vertical This study. Gaussian09 B3LYP 6-31+G* gas phase
−0.70 EA Vertical This study. Gaussian09 B3LYP 6-31+G* gas phase
6.85 IP Relaxed This study. Gaussian09 B3LYP 6-31+G* gas phase
−0.65 EA Relaxed This study. Gaussian09 B3LYP 6-31+G* gas phase
Table 2 Vertical IP and EA of selected conformers of melatonin at
B3LYP/6-31+G* PCM (water)
MOE conformer
energy (kcal mol−1) Vertical IP/eV Vertical EA/eV
20.573446 5.544 −0.886
20.573452 5.603 −0.739
21.250622 5.538 −0.879
21.250629 5.538 −0.879
21.694929 5.429 −0.947
21.694931 5.429 −0.947
21.724112 5.443 −0.952
Mean 5.5036 −0.8898
S.D. 0.0694 0.0745
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2014 Org. Biomol. Chem., 2014, 12, 7820–7827 | 7823
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
9 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
on
 1
2/
12
/2
01
4 
11
:2
7:
11
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
increasing the activity of the antioxidative defense systems.9,47
Researchers have reported that the peroxyl radical scavenger
ability of melatonin is better than of α-tocopherol, vitamin C
and reduced glutathione (GSH),48 and more potent than
xanthurenic acid, resveratrol, EGCG, vitamin C and α-lipoic
acid in inhibiting •OH-induced oxidative DNA damage gener-
ated by oxygen-derived free radicals from Fenton reaction.49
Melatonin has been demonstrated to reduce the formation of
8-hydroxy-2′-deoxyguanosine, a product of damaged DNA
repair, 60 to 70 times more eﬀectively than ascorbate or α-toco-
pherol.50 Melatonin also plays an important role in protecting
cellular membranes against lipid peroxidation.51
It should be noted that most other dietary antioxidants
lie outside the scale of this donor–acceptor map, towards the top
right quadrant, including carotenoids, psittacofulvins and antho-
cyanins, flavenoids and polyphenols. These tend to be electron
acceptors rather than electron donors i.e. antireductants.
Lipophilicity of antioxidant species
Log P values for melatonin and its metabolites and some clas-
sical antioxidants were calculated and compared to literature
values where available (Table 3). The compounds may be classi-
fied into roughly three groups – highly lipophilic compounds
(log P > 6) like α-tocopherol, vitamin A and beta-carotene
that mainly protect lipid membranes; vitamin C that is very
hydrophilic (log P < −3) and mainly protects aqueous cellular
and tissue environments; and the “melatonin type” com-
Fig. 4 Donor–acceptor map of melatonin and its metabolites, and other classical antioxidants.
Table 3 Calculated and experimental log P values
Log P
Antioxidant ACDa
Marvin
weightedb MolKac
Literature
values
Beta-carotene 15.51 ± 0.43 11.12 9.0 14.76
α-Tocopherol
(vitamin E)
10.66 ± 0.28 8.94 9.0 10.51d
Vitamin A (retinol) 6.84 ± 0.33 6.07 6.1 4.69–6.38e
Alpha-lipoic acid 2.16 ± 0.29 2.11 2.4 —
Melatonin 0.96 ± 0.44 1.41 1.4 1.254,55
6-OH-melatonin 0.02 ± 0.83 0.84 1.0 —
Melatoninyl neutral
radical
0.02 ± 0.83 0.88 — —
AFMK 0.82 ± 0.52 0.34 0.0 0.4856
AMK 0.65 ± 0.49 0.33 0.2 0.7456
−0.7758
Tryptophan 0.87 ± 0.31 1.51 0.6 1.0857
−1.0659
2-Naphthoyl-
melatonin
2.73 ± 0.46 3.31 3.7 —
2-Benzoyl-melatonin 1.5 ± 0.46 2.32 2.4 —
Cyclic-3OHmel −0.64 ± 0.89 −0.21 0.8 —
Acetyl-melatonin 1.00 ± 0.87 0.47 1.3 —
Vitamin C −3.26 ± 0.56 −1.98 −3.4 −1.8558
a ADC/Chemsketch log P plugin (Advanced Chemistry Development,
Inc., Toronto, Canada) 2012 http://www.acdlabs.com. bMarvinView
5.11.3 (Chemaxon, Budapest, Hungary) 2012 http://www.chemaxon.
com. cMoKa (Molecular Discovery Ltd, Perugia, Italy) 2012 http://www.
moldiscovery.com. d http://www.chemicalize.org/structure/#!mol=Vita+E.
eHuman Metabolome Database Version 3.6. http://www.hmdb.ca/
metabolites/HMDB00305.
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pounds that may be considered “amphiphilic” (log P between
−1 and 2). This latter group should be active antioxidants in
all cellular (cytosol and membrane) and tissues environments,
and may be important in regenerating some of the other
redox-cycling antioxidants like α-tocopherol, and mediating
antioxidant reactions at aqueous-lipid membrane interfaces.52
Melatonin has been shown to have strong synergistic eﬀects
with α-tocopherol and vitamin C.49,53
TBARS pIC50 results were correlated with a number of
derived electronic properties e.g. HOMO/LUMO energies,
donor and acceptor power (Rd, Ra), hardness, electronegativity
and log P, and results are shown in Table 4. Only lipophilicity
(log P) correlated well, correlation with other molecular pro-
perties (donor/acceptor power, electronegativity and LUMO
was poorer, with low or no correlation with hardness, HOMO
and HOMO/LUMO energy diﬀerence. This may be because of
the nature of the brain homogenate lipid peroxidation assay,
where solubility of the antioxidant in the lipid domain is the
dominant factor contributing to radical scavenging. The hydro-
phobicity of the antioxidant may also be an important cri-
terion for passive transport into cells across the hydrophobic
phospholipid bilayer of the cellular membranes. Furthermore,
the single electron transfer mechanism for direct radical
scavenging of melatonin, although the most favourable mech-
anism in aqueous solution, is not favourable in aprotic sol-
vents e.g. benzene, where hydrogen atom transfer/proton
coupled electron transfer or radical adduct formation are
favoured.29
By contrast, for the ORAC assay, which was performed
in aqueous medium, all molecular parameters correlated
highly with the ORAC AUC except for log P (Table 4), as
has been observed previously with indoleamines where
antioxidant potency was measured for lipid peroxida-
tion using a conjugated dienes assay60 and in phenolic
compounds.61
Some QSAR correlation plots are shown in Fig. 5, and all
correlation plots are shown in the ESI.†
Table 4 Correlation of TBARS pIC50 and ORAC AUC for melatonin and
3 derivatives with various calculated molecular parameters
Molecular
parameters
Correlation (r2) with
TBARS pIC50
Correlation (r2) with
ORAC log AUC
Donor power (Rd) 0.636 0.951
Acceptor power (Ra) 0.647 0.935
Hardness (η) 0.458 0.982
Electronegativity (X) 0.589 0.987
Energy HOMO (eV) 0.331 0.928
Energy LUMO (eV) 0.560 0.995
Energy HOMO–
LUMO (eV)
0.237 0.941
Log P 0.978 0.554
Fig. 5 QSAR correlation plots of some calculated molecular parameters and TBARS or ORAC antioxidant activity.
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Conclusions
The electron donor power of melatonin and its metabolites
demonstrated in this theoretical study support the experi-
mental evidence that melatonin is a powerful biological anti-
oxidant and radical scavenger. Our computational studies,
presented above, shed light on this important biological prop-
erty. We have shown that the B3LYP DFT method, along with
the 6-31+G(d) basis set, satisfactorily reproduces experimental
gas phase ionization potential and electron aﬃnity, while
larger basis sets do not improve performance. Importantly,
calculated properties are not dependent on molecular confor-
mation, such that data derived from a single conformation
should be suﬃcient to capture all relevant aspects of this
molecule.
This method has therefore been used to map out the
donor–acceptor power of melatonin, its metabolites, some syn-
thetic derivatives and a range of classical antioxidants. This
approach clearly shows that melatonin lies in the range of
good electron donors and bad electron acceptors, with similar
power to vitamin E. Interestingly, the first neutral, radical
metabolite of melatonin is an even better donor than the
parent molecule, which will have important implications for
the overall biology of the cascade process by which melatonin
mops up ROS. Other metabolites, as well as most synthetic
derivatives, remain in the range where substantial antioxidant
ability should be expected, but a 4-nitro derivative lies well
outside this region.
QSAR investigation indicates the ability of melatonin deriva-
tives to protect against lipid peroxidation of brain homogenate
strongly correlated with their lipophilicity (log P) but only
weakly to other molecular properties related to donor/acceptor
ability (donor/acceptor power, electronegativity, hardness,
HOMO, LUMO, HOMO-LUMO energies). By contrast, these
molecular parameters correlate strongly with ORAC anti-
oxidant power measured in aqueous phase.
The range of lipophilicity of melatonin and its metabolites
(log P between −1 and 2) may explain the large number of anti-
oxidant arenas where melatonin seems to play a role in pro-
tecting against ROS damage; they lie between the traditional
membrane protectors (α-tocopherol, vitamin A and caroten-
oids) and hydrophilic compounds (vitamin C, lipoic-acid) and
aqueous antioxidant enzymes.
Acknowledgements
This work was performed using the computational facilities
of the Advanced Research Computing @ Cardiﬀ (ARCCA)
Division, Cardiﬀ University and supported by the Melato-
nin Research Group, Khon Kaen University. Acknowledge-
ment is given to Dr Ploentip Puthongking for synthesis
and provision of melatonin derivatives, and Preeaporn
Plaimee and Chawapon Pipatwatcharadate for antioxidant
measurements.
References
1 J. H. Stehle, A. Saade, O. Rawashdeh, K. Ackermann, A. Jilg,
T. Sebestény and E. Maronde, J. Pineal Res., 2011, 51,
17–43.
2 D. X. Tan, R. Hardeland, L. C. Manchester, B. Poeggeler,
S. Lopez-Burillo, J. C. Mayo, R. M. Sainz and R. J. Reiter,
J. Pineal Res., 2003, 34(4), 249–259.
3 R. J. Reiter, L. C. Manchester and D. X. Tan, Nutrition,
2005, 21(9), 920–924.
4 A. Piechota, S. Lipińska, J. Szemraj and A. Goraca, Gen.
Physiol. Biophys., 2010, 29(2), 144–150.
5 M. Sae-Teaw, J. Johns, N. P. Johns and S. Subongkot,
J. Pineal Res., 2013, 55(1), 58–64.
6 G. R. Martinez, E. A. Almeida, C. F. Klitzke, J. Onuki,
F. M. Prado, M. H. Medeiros and P. Di Mascio, Endocrine,
2005, 27(2), 111–118.
7 R. Hardeland, D. X. Tan and R. J. Reiter, J. Pineal Res.,
2009, 47(2), 109–126.
8 A. Galano, D. X. Tan and R. J. Reiter, J. Pineal Res., 2013, 54
(3), 245–257.
9 D. X. Tan, R. J. Reiter, L. C. Manchester, M. T. Yan,
M. El-Sawi, R. M. Sainz, J. C. Mayo, R. Kohen, M. Allegra
and R. Hardeland, Curr. Top. Med. Chem., 2002, 2(2),
181–197.
10 D. X. Tan, L. C. Manchester, M. P. Terron, L. J. Flores and
R. J. Reiter, J. Pineal Res., 2007, 42(1), 28–42.
11 G. R. Buettner, Arch. Biochem. Biophys., 1993, 300(2),
535–543.
12 V. Motilva, S. García-Mauriño, E. Talero and M. Illanes,
J. Pineal Res., 2011, 51, 44–60.
13 D. P. Cardinali, V. Srinivasan, A. Brzezinski and
G. M. Brown, J. Pineal Res., 2012, 52, 365–375.
14 S. A. Rosales-Corral, D. Acuna-Castroviejo, A. Coto-Montes,
J. A. Boga, L. C. Manchester, L. Fuentes-Broto, A. Korkmaz,
S. Ma, D. X. Tan and R. J. Reiter, J. Pineal Res., 2012, 52,
67–202.
15 A. Brzezinski, Melatonin in humans, N. Engl. J. Med., 1997,
336, 186–195.
16 R. Hardeland, J. A. Madrid, D. X. Tan and R. J. Reiter,
J. Pineal Res., 2012, 52, 139–166.
17 A. Korkmaz, R. J. Reiter, T. Topal, L. C. Manchester, S. Oter
and D. X. Tan, Mol. Med., 2009, 15(1–2), 43–50.
18 N. P. Johns, J. Johns, S. Porasuphatana, P. Plaimee and
M. Sae-Teaw, J. Agric. Food Chem., 2013, 61(4), 913–919.
19 X. Ma, J. R. Idle, K. W. Krausz and F. J. Gonzalez, Drug
Metab. Dispos., 2005, 33, 489–494.
20 A. Galano, Phys. Chem. Chem. Phys., 2011, 13, 7147–7157.
21 A. Galano, D. X. Tan and R. J. Reiter, RSC Adv., 2014, 4,
5220–5227.
22 J. L. Gazquez, A. Cedillo and A. Vela, J. Phys. Chem. A, 2007,
111, 1966–1970.
23 A. Martínez, J. Phys. Chem. B, 2009, 113(10), 3212–3217.
24 A. Martínez, R. Vargas and A. Galano, J. Phys. Chem. B,
2009, 113(35), 12113–12120.
25 A. Galano, J. Phys. Chem. B, 2007, 111(44), 12898–12908.
Paper Organic & Biomolecular Chemistry
7826 | Org. Biomol. Chem., 2014, 12, 7820–7827 This journal is © The Royal Society of Chemistry 2014
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
9 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
on
 1
2/
12
/2
01
4 
11
:2
7:
11
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
26 A. Martínez, M. A. Rodríguez-Gironés, A. Barbosa and
M. Costas, J. Phys. Chem. A, 2008, 112(38), 9037–9042.
27 A. Martínez, J. Phys. Chem. B, 2009, 113(14), 4915–4921.
28 J. M. May, Z. C. Qu and S. Mendiratta, Arch. Biochem.
Biophys., 1998, 349(2), 281–289.
29 S. J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J. H. Lee,
S. Chen, C. Corpe, A. Dutta, S. K. Dutta and M. Levine,
J. Am. Coll. Nutr., 2003, 22, 18–35.
30 E. J. Costa, C. S. Shida, M. H. Biaggi, A. S. Ito and
M. T. Lamy-Freund, FEBS Lett., 1997, 416(1), 103–106.
31 A. Teixeira, M. P. Morfim, C. de Cordova, C. Charão,
V. R. de Lima and T. B. Creczynski-Pasa, J. Pineal Res.,
2003, 35(4), 262–268.
32 C. Rodriguez, J. C. Mayo, R. M. Sainz, I. Antolín, F. Herrera,
V. Martín and R. J. Reiter, J. Pineal Res., 2004, 36(1), 1–9.
33 J. C. Mayo, R. M. Sainz, I. Antoli, F. Herrera, V. Martin and
C. Rodriguez, Cell. Mol. Life Sci., 2002, 59, 1706–1713.
34 C. Phiphatwatcharaded, A. Topark-Ngarm, P. Puthongking
and P. Mahakunakorn, Drug Dev. Res., 2014, 75(4), 235–245.
35 J. K. Callaway, P. M. Beart and B. Jarrott, J. Pharmacol.
Toxicol. Methods, 1998, 39(3), 155–162.
36 L. T. Rael, G. W. Thomas, M. L. Craun, C. G. Curtis,
R. Bar-Or and D. Bar-Or, J. Biochem. Mol. Biol., 2004, 37(6),
749–752.
37 D. Huang, B. Ou and R. L. Prior, J. Agric. Food Chem., 2005,
53, 1841–1856.
38 R. L. Prior, X. Wu and K. Schaich, J. Agric. Food Chem.,
2005, 53, 4290–4302.
39 M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria,
M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone,
B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato,
X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng,
J. L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda,
J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao,
H. Nakai, T. Vreven, J. A. Montgomery Jr., J. E. Peralta,
F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers,
K. N. Kudin, V. N. Staroverov, R. Kobayashi, J. Normand,
K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar,
J. Tomasi, M. Cossi, N. Rega, N. J. Millam, M. Klene,
J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo,
R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin,
R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin,
K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador,
J. J. Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas,
J. B. Foresman, J. V. Ortiz, J. Cioslowski and D. J. Fox,
Gaussian 09 (Revision D.01), Gaussian, Inc., Wallingford,
CT, 2009.
40 Molecular Operating Environment (MOE), 2013.08; Chemi-
cal Computing Group Inc., 1010 Sherbooke St. West, Suite
#910, Montreal, QC, Canada, H3A 2R7, 2013.
41 G. Schaftenaar and J. H. Noordik, J. Comput. Aided Mol.
Des., 2000, 14, 123–134.
42 M. Leopoldini, T. Marino, N. Russo and M. Toscano,
J. Phys. Chem. A, 2004, 108, 4916–4922.
43 F. Jensen, J. Chem. Theory Comput., 2010, 6(9), 2726–2735.
44 T. Yanai, D. P. Tew and N. C. Handy, Chem. Phys. Lett.,
2004, 393(1–3), 51–57.
45 M. Kubota and T. Kobayashi, J. Electron Spectrosc. Relat.
Phenom., 2003, 128(2), 165–178.
46 P. H. Cannington and N. S. Ham, J. Electron Spectrosc.
Relat. Phenom., 1983, 32, 139.
47 R. J. Reiter, D. X. Tan, L. C. Manchester and W. Qi, Cell
Biochem. Biophys., 2001, 34, 237–256.
48 C. Pieri, M. Marra, F. Moroni, R. Recchioni and
F. Marcheselli, Life Sci., 1994, 55(15), PL271–PL276.
49 S. Lopez-Burillo, D. X. Tan, J. C. Mayo, R. M. Sainz,
L. C. Manchester and R. J. Reiter, J. Pineal Res., 2003, 34,
269–277.
50 W. Qi, R. J. Reiter, D. X. Tan, L. C. Manchester, A. W. Siu
and J. J. Garcia, J. Pineal Res., 2001, 29, 54–61.
51 A. Catalá, Curr. Mol. Med., 2007, 7(7), 638–649.
52 H. Sun, D. V. Greathouse, O. S. Andersen and R. E. Koeppe
2nd, J. Biol. Chem., 2008, 283(32), 22233–22243.
53 E. Gitto, D. X. Tan, R. J. Reiter, M. Karbownik,
L. C. Manchester, S. Cuzzocrea, F. Fulia and I. Barberi,
J. Pharm. Pharmacol., 2001, 53, 1393–1401.
54 L. Kikwai, N. Kanikkannan, R. J. Babu and M. Singh,
J. Controlled Release, 2002, 83(2), 307–311.
55 M. Mor, C. Silva, F. Vacondio, P. V. Plazzi, S. Bertoni,
G. Spadoni, G. Diamantini, A. Bedini, G. Tarzia, M. Zusso,
D. Franceschini and P. Giusti, J. Pineal Res., 2004, 36(2),
95–102.
56 C. Harthe, D. Claudy, H. Dechaud, B. Vivien-Roels, P. Pevet
and B. Claustrat, Life Sci., 2003, 73(12), 1587–1597.
57 Liquid Chromatography in Biomedical Analysis, J. Chromato-
graphy Library, ed. T. Hanai, Elsevier, New York, 1991, vol.
50.
58 A. Avdeef and K. J. Box, Sirius Technical Application Notes
(STAN), Sirius Analytical Instruments Ltd, Forest Row, UK,
1995, vol. 2.
59 M. Urakami, R. Ano, Y. Kimura, M. Shima, R. Matsuno,
T. Ueno and M. Z. Akamatsu, Z. Naturforsch C: Biosci.,
2003, 58(1–2), 135–142.
60 G. Spadoni, G. Diamantini, A. Bedini, G. Tarzia,
F. Vacondio, C. Silva, M. Rivara, M. Mor, P. V. Plazzi,
M. Zusso, D. Franceschini and P. Giusti, J. Pineal Res.,
2006, 40(3), 259–269.
61 L. V. B. Hoelz, B. A. C. Horta, J. Q. Araújo,
M. G. Albuquerque, R. B. de Alencastro and J. F. M. da
Silva, J. Chem. Pharm. Res., 2010, 2(5), 291–306.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2014 Org. Biomol. Chem., 2014, 12, 7820–7827 | 7827
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
9 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
on
 1
2/
12
/2
01
4 
11
:2
7:
11
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
